GSK-3 inhibitors

   
   

The invention provides compounds of formula (I) 1 the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R.sup.1, R.sup.2, and R.sup.3 are as defined herein; pharmaceutical compositions thereof; and use thereof in the treatment of, inter alia, conditions, diseases, and symptoms such as diabetes, dementia, Alzheimer's Disease, stroke, schizophrenia, depression, hair loss, and cancer.

Вымысел обеспечивает смеси формулы (I) 1 стереоизомеры и prodrugs thereof, и фармацевтически приемлемо соли смесей, стереоизомеров, и prodrugs, при котором R.sup.1, R.sup.2, и R.sup.3 как определено здесь; фармацевтические составы thereof; и польза thereof в обработке, inter alia, условиях, заболеваниях, и симптомах such as мочеизнурение, слабоумие, заболевание Alzheimer's, ход, шизофрения, нажатие, потеря волос, и рак.

 
Web www.patentalert.com

< 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands

< Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors

> Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5

> Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitors

~ 00159